Skip to Main Content
Contribute Try STAT+ Today

SAN DIEGO — Do the same thing over and over again for 18 years and you get used to it. That’s how Manny Johnson feels about the regularly scheduled blood transfusions he requires every month to keep the crippling, potentially life-threatening symptoms of sickle cell disease at bay.

“I was never bothered by it because it was just the way it was, it was part of me,” says Johnson, now 21, about the regimen of blood transfusions that began when the lifelong resident of Boston’s Mattapan neighborhood was 3 years old.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Comments are closed.